New diagnostic and therapeutic tools
against multidrug resistant tumours

We aim to improve both
the diagnosis and therapy
of multidrug resistant (MDR)
solid tumours.


Identification of new biomarkers and therapeutic targets for MDR tumours

Synthesis and nanodelivery strategies for new therapeutic tools against MDR tumours

Efficacy validation of new therapeutic tools against pre-clinical models of MDR tumours

Pharmacokinetics and ADMET of the new therapeutic tools; safety of the targets